{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:14:31Z","timestamp":1794899671264,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Suzhou Medical Engineering Collaborative Innovation Research Project","award":["SLJ2022001"],"award-info":[{"award-number":["SLJ2022001"]}]},{"name":"Suzhou Medical Engineering Collaborative Innovation Research Project","award":["SLJ2022001"],"award-info":[{"award-number":["SLJ2022001"]}]},{"name":"Suzhou Medical Engineering Collaborative Innovation Research Project","award":["SLJ2022001"],"award-info":[{"award-number":["SLJ2022001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05105-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:10:37Z","timestamp":1751368237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification of a LncRNA based CeRNA network signature to establish a prognostic model and explore potential therapeutic targets in gastric cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuanqing","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"11","key":"5105_CR1","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3390\/ijms21114012","volume":"21","author":"J Machlowska","year":"2020","unstructured":"Machlowska, J. et al. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment Strategies[J]. Int. J. Mol. Sci. 21 (11), 4012 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"5105_CR2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","volume":"39","author":"RE Sexton","year":"2020","unstructured":"Sexton, R. E. et al. Gastric cancer: a comprehensive review of current and future treatment strategies[J]. Cancer Metastasis Rev. 39 (4), 1179\u20131203 (2020).","journal-title":"Cancer Metastasis Rev."},{"issue":"15","key":"5105_CR3","doi-asserted-by":"publisher","first-page":"25713","DOI":"10.18632\/oncotarget.14879","volume":"8","author":"J Zhou","year":"2017","unstructured":"Zhou, J. et al. Clinical significance of circulating tumor cells in gastric cancer patients[J]. Oncotarget 8 (15), 25713\u201325720 (2017).","journal-title":"Oncotarget"},{"issue":"7414","key":"5105_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature11233","volume":"489","author":"S Djebali","year":"2012","unstructured":"Djebali, S. et al. Landscape of transcription in human cells[J]. Nature 489 (7414), 101\u2013108 (2012).","journal-title":"Nature"},{"issue":"3","key":"5105_CR5","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3748\/wjg.v22.i3.1213","volume":"22","author":"SS Xie","year":"2016","unstructured":"Xie, S. S. et al. Emerging roles of non-coding rnas in gastric cancer: pathogenesis and clinical implications[J]. World J. Gastroenterol. 22 (3), 1213\u20131223 (2016).","journal-title":"World J. Gastroenterol."},{"key":"5105_CR6","doi-asserted-by":"crossref","unstructured":"Taft, R. J. et al. Small RNAs Derived from snoRNAs[J] 151233\u20131240 (RNA (New York, N.Y.), 2009). 7.","DOI":"10.1261\/rna.1528909"},{"issue":"2","key":"5105_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: target recognition and regulatory functions[J]. Cell 136 (2), 215\u2013233 (2009).","journal-title":"Cell"},{"key":"5105_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2020.12.012","volume":"75","author":"EM McCabe","year":"2021","unstructured":"McCabe, E. M. & Rasmussen, T. P. LncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions[J]. Sem. Cancer Biol. 75, 38\u201348 (2021).","journal-title":"Sem. Cancer Biol."},{"issue":"1","key":"5105_CR9","doi-asserted-by":"publisher","first-page":"e703","DOI":"10.1002\/ctm2.703","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability[J]. Clin. Translational Med. 12 (1), e703 (2022).","journal-title":"Clin. Translational Med."},{"issue":"3","key":"5105_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena, L. et al. A cerna hypothesis: the rosetta stone of a hidden RNA language?[J]. Cell 146 (3), 353\u2013358 (2011).","journal-title":"Cell"},{"key":"5105_CR11","doi-asserted-by":"crossref","unstructured":"Th\u00e9ry, C. Exosomes: Secreted Vesicles and Intercellular Communications[J] 315 (F1000 Biology Reports, 2011).","DOI":"10.3410\/B3-15"},{"issue":"5","key":"5105_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy[J]. Nat. Med. 24 (5), 541\u2013550 (2018).","journal-title":"Nat. Med."},{"issue":"9","key":"5105_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim, S. T. et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer[J]. Nat. Med. 24 (9), 1449\u20131458 (2018).","journal-title":"Nat. Med."},{"issue":"1","key":"5105_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/cac2.12392","volume":"43","author":"Z Fang","year":"2023","unstructured":"Fang, Z. et al. Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives[J]. Cancer Commun. (London England). 43 (1), 3\u201341 (2023).","journal-title":"Cancer Commun. (London England)"},{"issue":"6","key":"5105_CR15","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","volume":"180","author":"KA Fitzgerald","year":"2020","unstructured":"Fitzgerald, K. A. & Kagan, J. C. Toll-like receptors and the control of Immunity[J]. Cell 180 (6), 1044\u20131066 (2020).","journal-title":"Cell"},{"issue":"6","key":"5105_CR16","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood, B., Najafi, M. & Mortezaee, K. CD8\u2009+\u2009cytotoxic T lymphocytes in cancer immunotherapy: a review[J]. J. Cell. Physiol. 234 (6), 8509\u20138521 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"5105_CR17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ccr.2014.03.010","volume":"25","author":"J Yuan","year":"2014","unstructured":"Yuan, J. et al. A long noncoding RNA activated by TGF-\u03b2 promotes the invasion-metastasis cascade in hepatocellular carcinoma[J]. Cancer Cell. 25 (5), 666\u2013681 (2014).","journal-title":"Cancer Cell."},{"issue":"19","key":"5105_CR18","doi-asserted-by":"publisher","first-page":"10201","DOI":"10.3390\/ijms221910201","volume":"22","author":"TL Mao","year":"2021","unstructured":"Mao, T. L. et al. LncRNA MALAT1 facilitates ovarian Cancer progression through promoting chemoresistance and invasiveness in the tumor microenvironment[J]. Int. J. Mol. Sci. 22 (19), 10201 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"5105_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41418-021-00879-9","volume":"29","author":"HT Liu","year":"2022","unstructured":"Liu, H. T. et al. LncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus[J]. Cell Death Differ. 29 (3), 627\u2013641 (2022).","journal-title":"Cell Death Differ."},{"issue":"4","key":"5105_CR20","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/1878-0261.12911","volume":"15","author":"F Teng","year":"2021","unstructured":"Teng, F. et al. LncRNA NKX2-1-AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR-2 signaling pathway in gastric cancer[J]. Mol. Oncol. 15 (4), 1234\u20131255 (2021).","journal-title":"Mol. Oncol."},{"issue":"1","key":"5105_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12957-022-02569-3","volume":"20","author":"Z Ji","year":"2022","unstructured":"Ji, Z. et al. LINC00922 acts as a novel oncogene in gastric cancer[J]. World J. Surg. Oncol. 20 (1), 121 (2022).","journal-title":"World J. Surg. Oncol."},{"key":"5105_CR22","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.12659\/MSM.916327","volume":"25","author":"T Liang","year":"2019","unstructured":"Liang, T. et al. LINC00922 accelerates the proliferation, migration and invasion of lung cancer via the miRNA-204\/CXCR4 Axis[J]. Med. Sci. Monitor: Int. Med. J. Experimental Clin. Res. 25, 5075\u20135086 (2019).","journal-title":"Med. Sci. Monitor: Int. Med. J. Experimental Clin. Res."},{"issue":"1","key":"5105_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13048-021-00828-7","volume":"14","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p[J]. J. Ovarian Res. 14 (1), 77 (2021).","journal-title":"J. Ovarian Res."},{"issue":"10","key":"5105_CR24","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1007\/s11010-021-04196-0","volume":"476","author":"Z Ye","year":"2021","unstructured":"Ye, Z. et al. LINC00922 promotes the proliferation, migration, invasion and EMT process of liver cancer cells by regulating miR-424-5p\/ARK5[J]. Mol. Cell. Biochem. 476 (10), 3757\u20133769 (2021).","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"5105_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s12013-021-00991-0","volume":"79","author":"E Wu","year":"2021","unstructured":"Wu, E. et al. Discovery of plasma membrane-associated rnas through APEX-seq[J]. Cell Biochem. Biophys. 79 (4), 905\u2013917 (2021).","journal-title":"Cell Biochem. Biophys."},{"issue":"12","key":"5105_CR26","doi-asserted-by":"publisher","first-page":"23658","DOI":"10.1002\/jcp.28933","volume":"234","author":"Y Chai","year":"2019","unstructured":"Chai, Y. & Xie, M. LINC01579 promotes cell proliferation by acting as a cerna of miR-139-5p to upregulate EIF4G2 expression in glioblastoma[J]. J. Cell. Physiol. 234 (12), 23658\u201323666 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"5105_CR27","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1053\/j.gastro.2020.11.044","volume":"160","author":"I Peran","year":"2021","unstructured":"Peran, I. et al. Cadherin 11 promotes immunosuppression and extracellular matrix deposition to support growth of pancreatic tumors and resistance to gemcitabine in Mice[J]. Gastroenterology 160 (4), 1359\u20131372e13 (2021).","journal-title":"Gastroenterology"},{"issue":"1","key":"5105_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7150\/jca.48193","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang, Z. et al. Downregulation of CDH11 promotes metastasis and resistance to paclitaxel in gastric Cancer Cells[J]. J. Cancer. 12 (1), 65\u201375 (2021).","journal-title":"J. Cancer"},{"issue":"1","key":"5105_CR29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s12885-019-5811-1","volume":"19","author":"JH Chen","year":"2019","unstructured":"Chen, J. H. et al. Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo[J]. BMC cancer. 19 (1), 634 (2019).","journal-title":"BMC cancer"},{"issue":"6","key":"5105_CR30","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.3390\/ijms23063214","volume":"23","author":"M Chivu-Economescu","year":"2022","unstructured":"Chivu-Economescu, M. et al. Collagen family and other matrix remodeling proteins identified by bioinformatics analysis as hub genes involved in gastric Cancer progression and Prognosis[J]. Int. J. Mol. Sci. 23 (6), 3214 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"5105_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bbrc.2021.07.005","volume":"570","author":"R Li","year":"2021","unstructured":"Li, R. et al. miR-543 impairs cell proliferation, migration, and invasion in breast cancer by suppressing VCAN[J]. Biochem. Biophys. Res. Commun. 570, 191\u2013198 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"5105_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12967-023-04303-3","volume":"21","author":"Q Ping","year":"2023","unstructured":"Ping, Q. et al. TGF-\u03b21 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells[J]. J. Transl. Med. 21 (1), 475 (2023).","journal-title":"J. Transl. Med."},{"issue":"15","key":"5105_CR33","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1158\/0008-5472.CAN-17-3014","volume":"78","author":"M Salem","year":"2018","unstructured":"Salem, M. et al. miR-590-3p promotes ovarian cancer growth and metastasis via a novel FOXA2-Versican pathway[J]. Cancer Res. 78 (15), 4175\u20134190 (2018).","journal-title":"Cancer Res."},{"key":"5105_CR34","doi-asserted-by":"publisher","first-page":"733745","DOI":"10.3389\/fonc.2021.733745","volume":"11","author":"L Yang","year":"2021","unstructured":"Yang, L. et al. Circular RNA Circ-0002570 accelerates cancer progression by regulating VCAN via MiR-587 in gastric cancer[J]. Front. Oncol. 11, 733745 (2021).","journal-title":"Front. Oncol."},{"key":"5105_CR35","doi-asserted-by":"publisher","first-page":"960570","DOI":"10.3389\/fimmu.2022.960570","volume":"13","author":"J Song","year":"2022","unstructured":"Song, J. et al. Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer[J]. Front. Immunol. 13, 960570 (2022).","journal-title":"Front. Immunol."},{"issue":"10","key":"5105_CR36","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1200\/JCO.2013.53.0105","volume":"32","author":"SL Topalian","year":"2014","unstructured":"Topalian, S. L. et al. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab[J]. J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol. 32 (10), 1020\u20131030 (2014).","journal-title":"J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol."},{"issue":"26","key":"5105_CR37","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer[J]. N. Engl. J. Med. 366 (26), 2443\u20132454 (2012).","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"5105_CR38","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. & Zhang, Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications[J]. Cell Mol. Immunol. 17 (8), 807\u2013821 (2020).","journal-title":"Cell Mol. Immunol."},{"issue":"9","key":"5105_CR39","doi-asserted-by":"publisher","first-page":"153093","DOI":"10.1016\/j.prp.2020.153093","volume":"216","author":"AL Zhou","year":"2020","unstructured":"Zhou, A. L. et al. Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma[J]. Pathol. Res. Pract. 216 (9), 153093 (2020).","journal-title":"Pathol. Res. Pract."},{"issue":"8","key":"5105_CR40","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamaoncol.2019.1549","volume":"5","author":"S Lu","year":"2019","unstructured":"Lu, S. et al. Comparison of biomarker modalities for predicting response to PD-1\/PD-L1 checkpoint blockade: a systematic review and Meta-analysis[J]. JAMA Oncol. 5 (8), 1195\u20131204 (2019).","journal-title":"JAMA Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05105-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05105-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05105-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:10:39Z","timestamp":1751368239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05105-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5105"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05105-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4989662\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20891"}}